Seeking Alpha

Pfizer's (PFE) planned $68B purchase of Wyeth (WYE) prompts the inevitable who's next?...

Pfizer's (PFE) planned $68B purchase of Wyeth (WYE) prompts the inevitable who's next? Bristol-Myers (BMY) is "most likely candidate for the next acquisition," Natixis Bleichroeder says, and could fetch $38/share. BMY +1.8% to $22.80.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs